BioCorRx Inc. (BICX) Financial Analysis and Rating

Comparison Analysis Based on SEC Data

Company Name BioCorRx Inc.
Industry (SIC) 8093 - Specialty Outpatient Facilities, Not Elsewhere Classified
Revenue in 2025 $797 thousand (ranked #74 out of 78 companies in the industry)
Assets as of 12/31/2025 $2,147 thousand (ranked #74)
Analyzed report 12/31/2024 (filed 3/31/2025)

Year:
20242025

Financial Position and Performance
Annual | Quarterly

Compared with 2024 industry ratios Change during the year

much worse
improved
Compared with all listed companies

much worse

Compare with a competitor

Financial Ratios Benchmarking

Financial Ratio Comparison of company ratios for 2024
with industry ratios
(80 - Health Services) 		with all listed companies
Solvency Ratios
Debt ratio 
33.01
0.56
33.01
0.61
Interest coverage ratio 
-9.84
-3.87
-9.84
2.45
Liquidity Ratios
Current Ratio 
0.01
1.53
0.01
1.78
Cash Ratio 
0.01
0.58
0.01
0.59
Profitability Ratios
Profit margin 
-67998.7%
-1.5%
-67998.7%
3%
ROA (Return on assets) 
-1341.7%
-2.3%
-1341.7%
0.9%
Activity Ratios
Asset turnover (days) 
18499
488
18499
776
Resulting score -1,9 -2,0

Year:
20242025

Additional Ratios (not used in score calculation)

Financial Ratio Comparison of company ratios for 2024
with industry ratios
(80 - Health Services) 		with all listed companies
Profitability Ratios
Gross margin 
78.3%
37.4%
78.3%
43.6%
Operating margin (Return on sales) 
-61727.9%
-2.9%
-61727.9%
5.1%
Activity Ratios
EBIT  $(5)M
EBITDA  $(4)M

Auditor's Conclusion

We have performed a comparative analysis of the balance sheet and income statement of BioCorRx Inc. (hereafter – the "Company") for the year 2024 as filed with the U.S. Securities and Exchange Commission (SEC). The primary business activity of the Company is "Specialty Outpatient Facilities, Not Elsewhere Classified" (SIC code 8093). In our analysis, we compared the key financial ratios of the Company with the average (median) values of those ratios calculated for the Company's specific industry sector and for all companies. The averages were calculated using data from 2024 financial statements filed with the SEC through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). By comparing each of the eleven key metrics to the median, we have reached an overall conclusion about the quality of the Company's financial condition. All calculations and conclusions were performed using software and methodologies developed by ReadyRatios.

Based on our analysis of the Company's key financial ratios, we have determined the following. The financial condition of BioCorRx Inc. in 2024 is much worse than the typical financial condition of companies in the "Specialty Outpatient Facilities, Not Elsewhere Classified" industry.

A comparison of the Company's financial ratios with the average ratios for all industries leads to the same conclusion. The financial position of BioCorRx Inc. is much worse than that of most listed companies that file financial statements with the U.S. Securities and Exchange Commission.

Financial Position and Performance History


More on BioCorRx Inc.

Closest Competitors

Company USD ($), in Millions
Revenue Assets
Marpai, Inc. 18 11
Pacific Health Care Organization Inc 7 13
BioRestorative The